تحلیل اختیاری محصول
با اجازه شما، از تحلیلهای محدود و حریمخصوصیمحور استفاده میکنیم تا مسیرهای پژوهشی مؤثر را بشناسیم. از ردیاب تبلیغاتی یا بازپخش نشست استفاده نمیکنیم. این انتخاب را میتوانید در تنظیمات تغییر دهید. بخوانید سیاست حفظ حریم خصوصی.
Alphabet Inc. Class C's published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $4.15T | |
|---|---|---|
| Revenue (ttm) | 445.9B | |
| Net income (ttm) | 244.1B | |
| EPS (ttm) | $19.9 | |
| Shares out | 12.2B | |
| P/E (trailing) | 16.1x | |
| P/E (forward) | 22.1x | |
| Dividend | $0.88 (0.27%) | |
| Volume | 17,944,160 | |
| Beta | 1.21 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $257.64B | $282.84B | $307.39B | $350.02B | $402.84B | +11.8% |
| Gross profit | $146.70B | $156.63B | $174.06B | $203.71B | $240.30B | +13.1% |
| Operating income | $78.71B | $74.84B | $84.29B | $112.39B | $129.04B | +13.2% |
| Net income | $76.03B | $59.97B | $73.80B | $100.12B | $132.17B | +14.8% |
| EPS (diluted) | $5.61 | $4.56 | $5.80 | $8.04 | $10.81 | +17.8% |
| EBITDA | $103.52B | $85.16B | $97.97B | $135.39B | $180.70B | +14.9% |
| R&D | $31.56B | $39.50B | $45.43B | $49.33B | $61.09B | +17.9% |
| SG&A | $13.51B | $15.72B | $16.43B | $14.19B | $21.48B | +12.3% |
Recent company headlines from major financial publishers.
If revenue meets expectations, profit and cash must still follow before the enlarged build creates enough value to change the valuation view.
This case strengthens if FY2027 revenue meets expectations and free cash flow improves despite the spending build. It weakens if higher spending keeps absorbing operating cash.
| Ke ↓ / g → | 2.0% | 2.5% | 3.0% | 3.5% | 4.0% |
|---|---|---|---|---|---|
| 7.9% | $343 | $356 | $371 | $390 | $414 |
| 8.9% | $308 | $317 | $327 | $338 | $353 |
| 9.9% | $282 | $288 | $295 | $303 | $312 |
| 10.9% | $261 | $266 | $270 | $276 | $282 |
| 11.9% | $244 | $248 | $251 | $255 | $259 |
Upcoming earnings date and setup when available.
رتبهای که نسخهٔ پژوهشی منتشرشدهٔ هر ماه داشت. رتبه قیمت در تاریخ تحلیل را با ارزش منصفانه مقایسه میکند و سابقهای از درستی یا نادرستی ارزیابی نیست.
| سال | دی | بهمن | اسفند | فروردین | اردیبهشت | خرداد | تیر | مرداد | شهریور | مهر | آبان | آذر |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
